Gilead Sciences, Inc.
December 1, 2016Oral Health and Dental Management for the Pregnant and Lactating Patient
This course will present the oral manifestations that may be encountered in pregnancy. Many myths re…
November 15, 2016YOU, ME AND H.PYLORI: Gastrointestinal Diseases and Their Dental Implications
Chronic gastric disorders are some of the most common systemic diseases encountered in our patients.
October 10, 2016Fighting Dental Caries and Beyond
This course will cover the caries process over time including the Caries Continuum including the imp…
September 20, 2016The Art and Science of Mechanically Controlling Plaque
Our goal is to inform about the process of oral hygiene and to arm pharmacists with an understanding…
September 15, 2016Anatomy of Toothpaste Exposed
This program will provide participants with an insight view of toothpaste. It will include a overvie…
July 5, 2016Oral Malodor: A Review of Key principles
This presentation will provide an examination and diagnosis of oral malodor including a comprehensiv…
July 1, 2016Heart Disease: The #1 Killer!
This course will look at risk factors for, and strategies for the prevention of, heart disease.
July 1, 2016Oral health and pulmonary disease
Recent research suggests an association between poor oral health status and pulmonary diseases such…
September 29, 2016 | BusinessPfizer close to acquisition of Medivation
NEW YORK, USA: Pfizer has announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired with respect to Pfizer’s pending acquisition of Medivation. Pfizer now …read article
October 14, 2016 | NewsCAPP Partners with Colgate Oral Care Academy for new concept: ‘Dental Hygienist Seminar’ – 05 Nov 2016
UBAI, UAE: Centre for Advanced Professional Practices (CAPP Events) has partnered with Colgate Oral Care Academy to bring forward a new concept for professional education and development in the MEA …read article
October 3, 2016 | NewsFDA grants accelerated approval to first drug for Duchenne muscular dystrophy
SILVER SPRING, Maryland, USA: The U.S. Food and Drug Administration has approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 …read article
October 13, 2016 | NewsPharmaceuticals could cause damage in aquatic environments
PLYMOUTH/LIVERPOOL, UK: Commonly used medications are not absorbed by riverine bacteria as might have been expected based on models and previous tests, British researchers have warned. According to their study, …read article